Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined MHT and GLP-1RA in Early Postmenopausal Women With or at Risk of Diabetes
NCT06715514Active, not recruiting
- Start
- Feb 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of estradiol and progesterone in type 2 diabetes mellitus (T2DM) (3 arms). Primary endpoint: Change in HbA1C at 12 weeks. Started Feb 2025; status: active, not recruiting.
02
Drugs
estradiolprogesterone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06715514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06715514.